Journal articles on the topic 'Pharmaceutical fraud'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pharmaceutical fraud.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Lu, Zhiqiang, Zaina Parvez Qureshi, Brian Chen, Sudha Xirasagar, Paul Ray, Gowtham Rao, Isaac Lopez, et al. "Why Is Cancer Care So Expensive: Potential Implications of Fraud and Abuse." Blood 120, no. 21 (November 16, 2012): 4275. http://dx.doi.org/10.1182/blood.v120.21.4275.4275.
Full textMa, Jianwei, Na Wang, and Qiangzu Li. "The Failure of Kangmei, the Lesson of A-Shares." International Business & Economics Studies 4, no. 2 (May 20, 2022): p88. http://dx.doi.org/10.22158/ibes.v4n2p88.
Full textValverde, José Luis. "Corporate responsibility and pharmaceutical fraud." Pharmaceuticals, Policy and Law 14, no. 2-4 (2012): 129–56. http://dx.doi.org/10.3233/ppl-120350.
Full textHoeksema, HL, J. Troost, DE Grobbee, WM Wiersinga, FCB van Wijmen, and EC Klasen. "Fraud in a pharmaceutical trial." Lancet 356, no. 9243 (November 2000): 1773. http://dx.doi.org/10.1016/s0140-6736(05)71970-x.
Full textLiu, Siyang. "The Impact of Chinas Independent Director System on Corporate Financial Fraud: The Case of Kangmei Pharmaceutical Fraud." Advances in Economics, Management and Political Sciences 4, no. 1 (March 21, 2023): 621–28. http://dx.doi.org/10.54254/2754-1169/4/2022980.
Full textCodaste, Harold L., Charlnette Mae T. Lasiste, and Alexander Franco A. Delantar. "Preliminary Fraud Risk Assessment of a Pharmaceutical Distributor." International Journal on Graft and Corruption 2, no. 1 (January 23, 2015): 11–23. http://dx.doi.org/10.7719/ijgc.v2i1.299.
Full textChen, Yaling, Shan Xiong, and Ting Duan. "A Case Study of Fraud in Xinjiang Ready Health Industry Co.,Ltd. Based on Fraud Triangle Theory." Frontiers in Business, Economics and Management 8, no. 2 (April 6, 2023): 134–38. http://dx.doi.org/10.54097/fbem.v8i2.7127.
Full textWhite, Jeb. "Masterminds behind pharmaceutical fraud deserve prison time." Nature Medicine 16, no. 9 (September 2010): 956. http://dx.doi.org/10.1038/nm0910-956.
Full text., Olivia. "PENGARUH PENGENDALIAN.INTERNAL, INDEPENDENSI, WHISTLEBLOWING SYSTEM, ANTI-FRAUD AWARENESS, DAN INTEGRITAS TERHADAP PENCEGAHAN FRAUD." Jurnal Ekonomi Trisakti 2, no. 2 (August 10, 2022): 261–72. http://dx.doi.org/10.25105/jet.v2i2.14217.
Full textDai, Liqin. "Identification of Financial Fraud in Listed Companies and Analysis of Preventive Measures - A Case Study of Kangmei Pharmaceutical." BCP Business & Management 27 (September 6, 2022): 350–62. http://dx.doi.org/10.54691/bcpbm.v27i.1982.
Full textAkomea-Frimpong, Isaac, and Charles Andoh. "Understanding and controlling financial fraud in the drug industry." Journal of Financial Crime 27, no. 2 (January 31, 2020): 337–54. http://dx.doi.org/10.1108/jfc-06-2019-0071.
Full textSetiyowati, Supami Wahyu, Mochamad Fariz Irianto, and Irma Tyasari. "Determinan Pencegahan Kecurangan Pengelolaan Dana Desa Dimoderasi Kompetensi Aparatur." Organum: Jurnal Saintifik Manajemen dan Akuntansi 5, no. 1 (June 30, 2022): 62–72. http://dx.doi.org/10.35138/organum.v5i1.197.
Full textKevorkova, Z. A., and I. A. Zhukova. "HIGH RISK AREAS OF FRAUD ON PHARMACEUTICAL MARKET." Современная экономика проблемы и решения, no. 2 (2023): 81–90. http://dx.doi.org/10.17308/meps/2078-9017/2023/2/81-90.
Full textLi, Yanan. "Identification and Audit Response of Financial Fraud in Listed Companies in Pharmaceutical Industry." Frontiers in Business, Economics and Management 7, no. 2 (February 5, 2023): 15–19. http://dx.doi.org/10.54097/fbem.v7i2.4353.
Full textKesselheim, Aaron S., David M. Studdert, and Michelle M. Mello. "Whistle-Blowers' Experiences in Fraud Litigation against Pharmaceutical Companies." New England Journal of Medicine 362, no. 19 (May 13, 2010): 1832–39. http://dx.doi.org/10.1056/nejmsr0912039.
Full textPeltier-Rivest, Dominic, and Carl Pacini. "Detecting counterfeit pharmaceutical drugs." Journal of Financial Crime 26, no. 4 (October 7, 2019): 1027–47. http://dx.doi.org/10.1108/jfc-06-2018-0057.
Full textShalaby, Azza Helmy Mahmoud, and Ahmad Abdulkareem Mohammad Al-Harkan. "The awareness of judicial accounting techniques towards the expectations of the external auditor in detecting fraud and its impact on the performance." Accounting 8, no. 3 (2022): 345–54. http://dx.doi.org/10.5267/j.ac.2021.10.003.
Full textQureshi, Zaina P. "Pharmaceutical Fraud and Abuse in the United States, 1996-2010." Archives of Internal Medicine 171, no. 16 (September 12, 2011): 1503. http://dx.doi.org/10.1001/archinternmed.2011.397.
Full textDewi, Nurul Hasanah Uswati, Putri Wulanditya, Dian Oktarina, and Herwin Ardianto. "Banking sector lack detection: Expectation gap between auditors and bankers." Accounting 7, no. 6 (2021): 1353–62. http://dx.doi.org/10.5267/j.ac.2021.4.002.
Full textAnas, Dadio Fiasani, and Anastasia Filiana Ismawati. "EFFECT FRAUD DIAMOND THEORY DETECTING FINANCIAL STATEMENT FRAUD WITH PANDEMIC AS CONTROL VARIABLE." JOURNAL OF ACCOUNTING, ENTREPRENEURSHIP AND FINANCIAL TECHNOLOGY (JAEF) 4, no. 1 (October 28, 2022): 15–28. http://dx.doi.org/10.37715/jaef.v4i1.2754.
Full textToothman, Myranda, Ken Moore, and Doohee Lee. "Unraveling Medicare and Medicaid Prescription Drug Fraud and Abuse." Compensation & Benefits Review 43, no. 6 (April 13, 2011): 339–45. http://dx.doi.org/10.1177/0886368711405018.
Full textAriyanto, Dodik, I. Made Gilang Jhuniantara, Ni Made Dwi Ratnadi, I. Gusti Ayu Made Asri Dwija Putri, and Ayu Aryista Dewi. "Detecting fraudulent financial statements in pharmaceutical companies: Fraud pentagon theory perspective." Accounting 7, no. 7 (2021): 1611–20. http://dx.doi.org/10.5267/j.ac.2021.5.009.
Full textBurrell, Darrell Norman, Sharon L. Burton, Delores Springs, Jorja B. Wright, Maurice D. Harmon, and Eugene J. M. Lewis. "A Qualitative Research Assessment of the MBA for 2020 and Beyond." International Journal of Smart Education and Urban Society 11, no. 3 (July 2020): 23–41. http://dx.doi.org/10.4018/ijseus.2020070103.
Full textHayashi, Merrick Max Dillard. "Pharmaceutical Phonies: The Entanglement of Fraud, Third-Party Payors, and Proximate Cause in Civil RICO Cases." Texas A&M Law Review 9, no. 4 (December 13, 2021): 1–11. http://dx.doi.org/10.37419/lr.v9.arg.1.
Full textBarrientos, Claudio, and Silvana Moris. "Teaching organic nomenclature for pharmacy students: Adapting a course to online mode during COVID-19." Pharmacy Education 22, no. 1 (May 28, 2022): 360–75. http://dx.doi.org/10.46542/pe.2022.221.360375.
Full textRosdini, Dini, Aria Farah Mita, and Dyah Setyaningrum. "Internal auditor reports a fraud: Courage and pressure." Accounting 7, no. 7 (2021): 1813–18. http://dx.doi.org/10.5267/j.ac.2021.6.001.
Full textRein, Frederick H., and Joseph B. Crystal. "Unigene Laboratories, Inc. et al. v. Apotex, Inc. et al.: Reformulating an old drug is not as obvious as one might think." Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 9, no. 1 (March 2012): 36–44. http://dx.doi.org/10.1177/1741134311433733.
Full textWidiastika, Audri, and Junaidi Junaidi. "Fraud Pentagon dalam Mendeteksi Kecurangan Laporan Keuangan." Jurnal Akuntansi, Keuangan, dan Manajemen 3, no. 1 (December 25, 2021): 83–98. http://dx.doi.org/10.35912/jakman.v3i1.747.
Full textGreenman, Zac, and Dr Cindy Greenman, CFE. "Pharmaceutical Fraud: Off-Label Marketing of Drugs in the United States, 2009-2016." Research in Economics and Management 2, no. 5 (October 26, 2017): 198. http://dx.doi.org/10.22158/rem.v2n5p198.
Full textPatria, Harry. "Predicting Fraudulence Transaction under Data Imbalance using Neural Network (Deep Learning)." Data Science: Journal of Computing and Applied Informatics 6, no. 2 (July 31, 2022): 67–80. http://dx.doi.org/10.32734/jocai.v6.i2-8309.
Full textNanda, Satria tri, Neneng Salmiah, and Dina Mulyana. "FRAUDULENT FINANCIAL REPORTING: A PENTAGON FRAUD ANALYSIS." Jurnal Ilmiah Ekonomi Dan Bisnis 16, no. 2 (September 24, 2019): 122–34. http://dx.doi.org/10.31849/jieb.v16i2.2678.
Full textHorowitz, Arthur M. "Fraud and Investigator Integrity in Clinical Research." Clinical Research and Regulatory Affairs 12, no. 2 (January 1995): 131–41. http://dx.doi.org/10.3109/10601339509079583.
Full textHaddab, Daniella Maya. "Detecting banking frauds with analytics and machine learning." Business & IT XIII, no. 1 (2023): 90–96. http://dx.doi.org/10.14311/bit.2023.01.11.
Full textBudiman, Monika, Choirul Anwar, and Sudjono Sudjono. "FACTORS AFFECTING FRAUD PREVENTION AND ITS IMPLICATION TO THE QUALITY OF FINANCIAL STATEMENTS." Journal of Applied Finance & Accounting 8, no. 1 (March 30, 2022): 1–25. http://dx.doi.org/10.21512/jafa.v8i1.6858.
Full textCarder, Elizabeth B., and Joseph W. Metro. "Appendix A. Minefields for the Unwary: Fraud and Abuse Issues Affecting Pharmaceutical Manufacturers." Journal of Pharmaceutical Marketing & Management 12, no. 2-3 (January 1998): 125–44. http://dx.doi.org/10.3109/j058v12n02_13.
Full textQureshi, Z., O. Sartor, and C. Bennett. "PHP3 FEDERAL ENFORCEMENT ACTIONS AGAINST FRAUD AND ABUSE BY PHARMACEUTICAL MANUFACTURERS: 1996-2010." Value in Health 14, no. 3 (May 2011): A12. http://dx.doi.org/10.1016/j.jval.2011.02.077.
Full textRazali, Nur Amira Hidayah, Wan Rosalili Wan Rosli, and Mohd Bahrin Othman. "The Legal Protection of E-Consumers Against E-Commerce Fraud in Malaysia." Malaysian Journal of Social Sciences and Humanities (MJSSH) 7, no. 9 (September 30, 2022): e001778. http://dx.doi.org/10.47405/mjssh.v7i9.1778.
Full textFaunce, Thomas A., Gregor Urbas, and Lesley Skillen. "Implementing US‐style anti‐fraud laws in the Australian pharmaceutical and health care industries." Medical Journal of Australia 194, no. 9 (May 2011): 474–78. http://dx.doi.org/10.5694/j.1326-5377.2011.tb03066.x.
Full textBraillon, Alain. "Implementing US‐style anti‐fraud laws in the Australian pharmaceutical and health care industries." Medical Journal of Australia 195, no. 10 (November 2011): 585. http://dx.doi.org/10.5694/mja11.10601.
Full textKhuluqi, Khusnul, and Napisah. "Pengaruh Fraud Pentagon Terhadap Kecurangan Laporan Keuangan Dengan Ukuran Perusahaan Sebagai Pemoderasi." WACANA EKONOMI (Jurnal Ekonomi, Bisnis dan Akuntansi) 21, no. 2 (November 2, 2022): 198–211. http://dx.doi.org/10.22225/we.21.2.2022.198-211.
Full textVictory, Chika Odukwu, Eke Promise, and Chukwumati N. Mike. "Impact of Cyber-Security on Fraud Prevention in Nigerian Commercial Banks." Jurnal Akuntansi, Keuangan, dan Manajemen 4, no. 1 (December 19, 2022): 15–27. http://dx.doi.org/10.35912/jakman.v4i1.1527.
Full textCheng, Ching Hung, Zhe Huang, Siqi Lin, and Hangyu Wu. "Analysis of Corporation’s Financial Fraud and Independent Directors’ Decision Based on Evolutionary Game Theory." BCP Business & Management 31 (November 5, 2022): 195–204. http://dx.doi.org/10.54691/bcpbm.v31i.2561.
Full textLiu, Mengna, and Jinshi Chen. "A Critical Metaphor Analysis of Anti-telefraud Public Legal Education Discourse." International Journal of Linguistics, Literature and Translation 5, no. 3 (March 13, 2022): 108–13. http://dx.doi.org/10.32996/ijllt.2022.5.3.14.
Full textLlarena, Zharama. "Organized Corporate Crimes using UNCITRAL Arbitration Framework Development for EPC Disclosure concerning Epistemic Corruption and Pharmaceutical Fraud of Off-label Medicines as Health Regulation and Policy." International Journal of Communication and Public Relation 8, no. 1 (February 27, 2023): 40–55. http://dx.doi.org/10.47604/ijcpr.1787.
Full textGabriel, Joseph M., and Bennett Holman. "Clinical trials and the origins of pharmaceutical fraud: Parke, Davis & Company, virtue epistemology, and the history of the fundamental antagonism." History of Science 58, no. 4 (July 25, 2020): 533–58. http://dx.doi.org/10.1177/0073275320942435.
Full textMironova, O. I., L. A. Ruonala, and E. S. Mironov. "Digitalization of Social Contacts – Risks for Women Seeking a Spouse through Dating Sites and Apps." Psychology and Law 11, no. 4 (2021): 42–63. http://dx.doi.org/10.17759/psylaw.2021110404.
Full textSetiyorini, Ika, and Desi Susilawati. "Accounting Information System And Prevention Of Fraudulent Drug Supply At The Kardinah Tegal General Hospital." Proceedings University of Muhammadiyah Yogyakarta Undergraduate Conference 2, no. 1 (June 30, 2022): 45–58. http://dx.doi.org/10.18196/umygrace.v2i1.412.
Full textFerguson, Brian. "Fraud and misconduct in medical research Summary of the report of the Royal College of Physicians." Psychiatric Bulletin 16, no. 10 (October 1992): 628–29. http://dx.doi.org/10.1192/pb.16.10.628.
Full textBrondz, Ilia. "Analytical Methods in Quality Control of Scientific Publications Part IV: Fraud Ordered by the Pharmaceutical Industry." International Journal of Analytical Mass Spectrometry and Chromatography 02, no. 04 (2014): 103–12. http://dx.doi.org/10.4236/ijamsc.2014.24009.
Full textShah, Udayan K., Douglas R. Johnston, Gina Maisto Smith, Barbara E. Ziv, and James S. Reilly. "Article Commentary: Penalties for health care fraud and abuse: January 2007-March 2008." Otolaryngology–Head and Neck Surgery 140, no. 5 (May 2009): 625–28. http://dx.doi.org/10.1016/j.otohns.2008.12.032.
Full text